Search Tag: rare diseases
2024 20 Feb
Individualized therapies and the integration of the patient's perspective are becoming increasingly important. February 29 is Rare Disease Day. On this occasion, the Austrian pharmaceutical company AOP Orphan Pharmaceuticals GmbH (AOP Health) takes a look at the challenges faced by patients with rare diseases and highlights the trends...Read more
2024 24 Jan
Seasoned leader in drug discovery and development OrphAI Therapeutics Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases the appointment of Jay S. Fine, Ph.D. to its Board of Directors. Dr. Fine has a strong track record of drug discovery and development leadership in respiratory diseases,...Read more
2023 06 Dec
AOP Health: Bianca Tan Assuming New Position as Therapeutic Area Director Cardiology and Pulmonology. In 2006, Bianca Tan started her career at AOP Orphan Pharmaceuticals GmbH (AOP Health), an Austrian pharmaceutical company with headquarters in Vienna that specializes in rare diseases and intensive care medicine. She has worked in various departments...Read more
2023 14 Nov
To ensure the availability of new therapies for rare diseases, a functioning cooperation between the public sector, academic research and research-based companies is crucial. With this in mind, Vienna's City Councilor for Health, Social Affairs and Sport, Peter Hacker, paid the Austrian pharmaceutical company AOP Orphan Pharmaceuticals GmbH ("AOP Health")...Read more
2019 22 May
How can healthcare accelerate the implementation of the science? Where is Personalised Medicine (PM) already improving the lives of patients and what is needed to make it the standard of care across multiple conditions? What’s your brief at the PMC? I have a science and genetics background and bring scientific...Read more
2015 27 Feb
Rare Disease Day is observed on the final day of February each year. What began as a European event has become a worldwide campaign, with thousands of events taking place in dozens of countries. This year, the theme is “Living with a Rare Disease”, which recognises the millions of family members and friends supporting patients with rare diseases. The...Read more
2015 12 Jan
The European Medical Agency (EMA) has shown its support for a record number of orphan medicines in 2014. Out of a total of 82 medicines for human use, 17 are indicated for the treatment of a rare disease. EMA has given positive opinions on 40 new non-orphan drugs, three biosimilars, one drug for paediatric use and 21 generic, hybrid and informed consent...Read more